David McNeely, MD
Cardiovascular Disease · Greenville, SCNPI 1285952705
Payments from drug & device makers
Across 465 payments — averaging $167.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$51K
- Edwards Lifesciences$10K
- Abbott$8K
- Boston Scientific$2K
- Novartis$1K
- Heartflow, Inc.$650
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 83 | $51,088 |
| Edwards Lifesciences | 11 | $10,142 |
| Abbott | 74 | $8,438 |
| Boston Scientific | 66 | $2,192 |
| Novartis | 61 | $1,080 |
| Heartflow, Inc. | 7 | $650 |
| Amgen | 21 | $474 |
| Boehringer Ingelheim | 27 | $466 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $446 |
| Alnylam Pharmaceuticals Inc. | 18 | $300 |
| Siemens Medical Solutions USA, Inc. | 3 | $236 |
| Astellas Pharma US Inc | 5 | $178 |
| Johnson & Johnson | 9 | $175 |
| Impulse Dynamics (USA) Inc. | 1 | $173 |
| E.r. Squibb & Sons, L.L.C. | 11 | $166 |
| Pfizer | 5 | $162 |
| Abiomed | 3 | $150 |
| Trisalus Life Sciences, Inc. | 1 | $140 |
| Bayer | 7 | $131 |
| Philips North America LLC | 6 | $130 |
| Actelion Pharmaceuticals US, Inc. | 1 | $123 |
| Merck | 7 | $111 |
| Atricure, Inc. | 5 | $103 |
| Teleflex LLC | 2 | $80 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $56 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $46 |
| Novo Nordisk | 2 | $43 |
| Terumo Medical Corporation | 1 | $32 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Daxor Corporation | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $24 |
| Cardiovascular Systems Inc. | 2 | $23 |
| Cvrx, Inc. | 1 | $21 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Chiesi USA, Inc. | 1 | $12 |
How this compares
$77,692 in reported general payments places this provider in the 90th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Greenville
- James MerriamGreenville$728K
- Arthur EberlyGreenville$438K
- Gregory SanGreenville$429K
- Dev VazGreenville$257K
- John CebeGreenville$152K
- Mark GrabarczykGreenville$78K
- Christopher SalmonGreenville$54K
- Christopher SmithGreenville$47K
- Arthur SiachosGreenville$29K
- Jon BittrickGreenville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.